Initial Statement of Beneficial Ownership (Form 3)

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Scholl Hendrik Peter 2. Date of Event Requiring Statement (Month/Day/Year) 03/18/2026 3. Issuer Name and Ticker or Trading Symbol BELITE BIO, INC [BLTE] (Last) (First) (Middle) GOTTHARDSTRASSE 26 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Medical Officer 5. If Amendment, Date Original Filed (Month/Day/Year) (Street) ZUG 6300 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Ordinary Share 35,000 I By Bioptima Ltd.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	(1)	08/31/2034	Ordinary Shares	100,000	$48.68	I	By Bioptima Ltd.
Stock Option (right to buy)	(2)	02/11/2035	Ordinary Shares	75,000	$54.88	I	By Bioptima Ltd.
Stock Option (right to buy)	(3)	01/08/2036	Ordinary Shares	40,000	$158.36	I	By Bioptima Ltd.

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Scholl Hendrik Peter GOTTHARDSTRASSE 26 ZUG 6300			Chief Medical Officer

Signatures

/s/ Hendrik Peter Scholl		03/18/2026
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The option shall vest (i) as to 50,000 ordinary shares on the first anniversary of September 1, 2024, and (ii) as to 50,000 ordinary shares in 24 equal and continuous monthly installments for each full month following the first anniversary of September 1, 2024, subject to continued service to the Issuer on each such date.
(2)	The option shall vest (i) as to 12,500 ordinary shares on September 1, 2025, and (ii) as to 62,500 ordinary shares in 30 equal and continuous monthly installments for each full month following September 1, 2025, subject to continued service to the Issuer on each such date.
(3)	The option shall vest (i) as to 13,333 ordinary shares on January 9, 2027, (ii) as to 13,333 ordinary shares on January 9, 2028, and (iii) as to 13,334 ordinary shares on January 9, 2029.
Remarks: Exhibit 24 - Power of Attorney

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.